No-reflow Phenomenon
📧 Sign up to get email alerts when something new happens for No-reflow Phenomenon.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Empagliflozin for No-reflow Phenomenon in PCI for STEMI [Phase 2]
Phase 2 clinical trial evaluating Empagliflozin for the no-reflow phenomenon during PCI in STEMI patients; the trial is currently active but…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Validation of New Biomarkers for Predicting No-Reflow in STEMI Patients Undergoing Primary PCI
A clinical trial update on validating new biomarkers to predict no-reflow in STEMI patients undergoing primary PCI, currently not yet recrui…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow [Phase 3]
A Phase 3 clinical trial from Ain Shams University evaluates intracoronary adrenaline administered via catheter during primary PCI in STEMI …
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of DecREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease [Phase 4]
Phase 4 clinical trial evaluating whether pre-procedural intracoronary nicorandil can prevent reduced TIMI flow during percutaneous coronary…
-
CLINICAL_TRIALS research · 2014-12-03Clinical Trial Update: Analysis of Human Coronary Aspirate
This clinical trial update summarizes an analysis of human coronary aspirate in patients with coronary artery disease. The conditions noted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.